Skip to content

ACLX

Arcellx, Inc.

NASDAQ · Healthcare · Biotechnology · US

$115.07
+0.02%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue22.3M22.3M107.9M110.3M
Cost of Revenue36.7M6.7M5.2M2.2M
Gross Profit(14.4M)15.6M102.7M110.3M(2.2M)
Operating Expenses
R&D Expense157.6M157.6M157.1M133.8M149.6M
SG&A Expense116.1M117.8M88.4M66.3M41.7M
General & Admin Expense86.5M117.8M88.4M66.3M41.7M
Selling & Marketing Expense
Other Expenses(35.1M)(6.7M)(5.2M)(2.2M)
Total Operating Expenses238.6M268.7M240.3M200.2M189.0M
Cost and Expenses275.4M275.4M245.5M200.2M191.3M
Operating Income (EBIT)(253.1M)(253.1M)(137.6M)(89.9M)(191.3M)
Non-Operating
Interest Income25.2M33.3M23.7M4.3M
Interest Expense24.2M24.2M1.0M3.8M1.7M
Net Interest Income1.0M(24.2M)32.3M19.9M2.6M
Other Non-Op Income/Expense24.2M24.2M32.3M19.9M2.6M
Non-Operating Income (excl Interest)(48.4M)(48.4M)(33.3M)(23.7M)(4.3M)
EBT (Pre-Tax Income)(228.9M)(228.9M)(105.3M)(70.0M)(188.7M)
Income Tax Expense69.0K69.0K2.1M663.0K
Bottom Line
Net Income(228.9M)(228.9M)(107.3M)(70.7M)(188.7M)
Earnings from Cont. Ops(228.9M)(228.9M)(107.3M)(70.7M)(188.7M)
Earnings from Discont. Ops
Bottom Line Net Income(228.9M)(228.9M)(107.3M)(70.7M)(188.7M)
Per Share
Basic EPS($4.07)($4.07)($2.00)($1.47)($4.28)
Diluted EPS($4.06)($4.07)($2.00)($1.47)($4.28)
Revenue Per Share$0.40$0.40$2.02$2.30$0.00
Shares
Basic Shares Outstanding56.3M56.3M53.6M48.1M44.1M
Diluted Shares Outstanding56.3M56.3M53.6M48.1M44.1M
Profitability Metrics
EBITDA(198.0M)(198.0M)(99.1M)(64.1M)(184.7M)
D&A6.7M6.7M5.2M2.0M2.2M
EBIT(204.6M)(204.6M)(104.2M)(66.2M)(187.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025